Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy
{{output}}
Introduction: Multiple intravenous doses of ponezumab, an anti-amyloid antibody, were evaluated in subjects with mild-to-moderate Alzheimer's disease (AD). Method... ...
